Home » Topics » Regulatory » Patents

Patents
RSS

Roche discloses new MAGL inhibitors

March 24, 2022

Kezar Life Sciences presents new protein secretion inhibitors

March 24, 2022

Korean researchers identify new NADPH oxidase inhibitors

March 24, 2022

Massachusetts Institute of Technology divulges new c-Myb inhibitors

March 24, 2022

Emory University patents thymidylate synthase inhibitors

March 24, 2022

Abbisko Therapeutics synthesizes new FGFR2/FGFR3 inhibitors

March 23, 2022

Cullgen discovers new PROTACs

March 23, 2022

NALO Therapeutics identifies new c-Myc and/or N-myc degradation inducers

March 23, 2022

Kumquat Biosciences patents new GTPase KRAS inhibitors

March 23, 2022

Gasherbrum Bio discloses GLP-1 receptor agonists

March 23, 2022

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...